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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489 S223an increased risk of post-operative in-hospital adverse events. While no
signiﬁcant differences were seen in discharge disposition, patients with
multiple symptomatic joints spent an average of half a day longer in
hospital before discharge when compared to those with symptoms in
the operated joint only, and accrued almost 10% greater costs from the
hospital perspective. Physicians and other health care decision makers
should be aware that multi-joint OA may characterize a distinct clinical
entity that may warrant speciﬁc attention.
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MULTIPLE SYMPTOMATIC JOINTS ARE ASSOCIATED WITH
INCREASED IN-HOSPITAL RESOURCE UTILIZATION AMONG
PATIENTS UNDERGOING TOTAL HIP ARTHROPLASTY FOR
OSTEOARTHRITIS
M.G. Zywiel, L.D. Djelic, R. Chaudhary, Y.R. Rampersaud, R. Gandhi,
N.N. Mahomed, A.V. Perruccio. Arthritis Program, University Health
Network; Univ. of Toronto, Toronto, ON, Canada
Purpose: The presence of multiple symptomatic joints has been asso-
ciated with worse pre-operative knee-speciﬁc pain and function in
patients undergoing total knee arthroplasty for osteoarthritis (OA).
However, it remains unknown whether similar patterns are seen in
patients with end-stage hip OA. The purpose of the present study was to
evaluate whether the presence of multiple symptomatic joints is
associated with differences in pre-operative hip-speciﬁc pain and
function, American Society of Anesthesiologists (ASA)class, adverse
event rates, length of stay, discharge disposition, or episode of care costs
in patients undergoing primary total hip arthroplasty (THA) for OA.
Methods: All patients who underwent primary THA for OA at a single
institution between April 2011 and October 2012 were reviewed.
Patients with a history of rheumatoid arthritis or inﬂammatory
arthropathy were excluded. Prospectively collected demographic and
clinical data, including number and location of symptomatic joints, as
well as ASA class and discharge disposition were extracted and linked
with hospital administrative data. Patients were grouped into three
categories: 1) symptoms in the operated joint only, 2) symptoms in a
total of 2–4 joints, and 3) ﬁve or more symptomatic joints. A total of 203
patients were included, with 46, 96, and 61 in each group, respectively.
Differences in hospital costs and length of stay were extrapolated to
determine the potential nationwide health services impact of multi-
joint osteoarthritis in Canada and the United States.
Results: Increasing symptomatic joint count was associated with sig-
niﬁcantly worse hip-speciﬁc mean WOMAC pain (8.59, 9.3, and 10.5
points respectively; p ¼ 0.018) and function (29.9, 32.2 and 37.2 points
respectively; p ¼ 0.010) scores, as well as greater mean ASA class (p ¼
0.001). The difference in mean length of stay between single joint and
5þ symptomatic joints groups was 0.17 days (one additional in-hospital
day for every 6 patients), irrespective of whether all patients or only
those patients discharged home were considered. No differences in the
incidence of adverse events were seen. However, the presence of ﬁve or
more symptomatic joints was associated with signiﬁcantly greater in-
hospital episode of care costs (10% incremental difference compared to
the single joint group; p ¼ 0.029), irrespective of discharge disposition.
Assuming the 30% prevalence of multiple symptomatic joints observed
in the present sample is representative of the nationwide population of
patients undergoing THA, this is conservatively estimated to represent
an incremental burden from the hospital perspective of $8,296,000
(CAD) when compared to procedures performed in patients with a
single symptomatic joint, and an additional 1,543 in-hospital bed-days.
When extrapolated to case volumes in the United States, this represents
an incremental cost burden of $67,356,000 (USD) and an additional
12,903 hospital bed-days to the US healthcare system in 2010, poten-
tially rising to $152,283,000 unadjusted USD and an additional 29,172
hospital bed-days by 2030.
Conclusions: Given the large and increasing number of patients
undergoing THA, the presence of multiple symptomatic joints may have
substantial health services implications as a result of higher incre-
mental hospital costs and increased length of stay. Further study is
needed to better characterise the differences in in-hospital health
resource requirements to identify the speciﬁc reasons for these dis-
parities. However, physicians and other health care decision makersshould be aware that OA associated with multiple symptomatic joints
may characterize a distinct clinical entity, potentially warranting spe-
ciﬁc attention and intervention.
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ARTHRITIS AND BACK PAIN IMPACT RESPIRATORY-SPECIFIC
QUALITY OF LIFE MEASURES IN SMOKERS WITH AND WITHOUT
COPD
E.A. Regan y, G.L. Kinney z, J. Black-Shinn z, M-L. McDonald x,
F. Jacobson x, B. Make y, J. Hokanson z, E. Silverman x, J.D. Crapo y. yNatl.
Jewish Hlth., Denver, CO, USA; zUniv. of Colorado Denver, Denver, CO, USA;
xBrigham and Women’s Hosp. and Harvard Med. Sch., Boston, MA, USA
Purpose: COPD affects more than 10 million people in the US and
approximately 49% of the US population over age 45 is a current or ex-
smoker. Comorbid arthritis and degenerative spine disease occur in
aging smokers but the prevalence of these conditions in smokers and
their impact on respiratory-speciﬁc quality of life measures has not
been studied. We hypothesized that either condition might impact the
St George Respiratory Questionnaire (SGRQ) – which is the most com-
monly used instrument in both COPD clinical trials and the assessment
of COPD progression. We have previously found strong associations of
osteoporosis to smoking and COPD severity.
Methods: COPDGene is a longitudinal cohort of 10,192 current and ex-
smokers, age 45 -80, designed to assess subtypes of COPD and their
genetic associations. Baseline cross-sectional data from the smoker
controls and from COPD subjects was used. Study data included self-
reports of musculoskeletal diseases and physical complaints. We
identiﬁed those with osteoarthritis (OA) based on self-report of
physician-diagnosis. Chronic back pain was identiﬁed by a positive
response to “Do you have lower back, buttock, or radiating leg pain
most days of the month?” We determined the prevalence of OA and
Chronic Back Pain (CBP) by age groups and by severity of lung disease.
Using multivariable regression adjusting for age, gender, obesity and
race, we tested the association of current smoking and pack years to
OA and chronic back pain. We compared these results to similar
analyses of self-reported osteoporosis, osteoporosis based on volu-
metric QCT measures, and rheumatoid arthritis based on self-report
and disease-modifying anti-rheumatic drugs (DMARD) use. Multi-
variable regression (adjusting for age, gender, race, smoking status and
pack years) was used to assess the impact of each of these conditions
on SGRQ scores and on the SF-36.
Results: Self-reported OA is slightly more prevalent in COPD cases (21%)
than controls (17%) in univariate analysis but the association is not
present after adjustment for age, gender, and race (OR 0.9, 95% CI 0.8–
1.0, p ¼ 0.07). There are expected associations to female gender, obesity
and increased age in univariate and multivariable analyses. In this
smoker cohort, the overall prevalence of OA is 19% but increases by age
group up to 40% in the 60–70 year old age group. Neither current
smoking nor pack years were associated with OA in multivariable
models. Chronic back pain is also not associated with COPD, but is
strongly associated with African American race, female gender, obesity,
current smoking and pack years in multivariable models. Both OA and
back pain have signiﬁcant negative effects on respiratory health status
exceeding the minimal clinically signiﬁcant difference of 4 units in
COPD patients), but the magnitude of the effect from chronic back pain
is three-fold greater than OA (range 11 -20 units). The generic quality of
life instrument, SF-36 showed similar results with both conditions
demonstrating signiﬁcant impairment, but chronic back pain had a 3 to
5-fold greater effects on physical function, bodily pain and physical
component scores.
Conclusions: Osteoarthritis and chronic back pain are common in a
smoking cohort and in COPD patients, but show divergent associations
with smoking. Chronic back pain has much greater impact on quality of
life than osteoarthritis of the lower extremities. Both conditions affect
quality of life measurements using a respiratory-speciﬁc instrument.
Clinical trials that use the SGRQ to measure outcomes of treatment in
COPD should assess subjects for OA and chronic spine disease to avoid
confounding. Drug treatments for COPD that are directed toward con-
trolling inﬂammation may improve respiratory-speciﬁc quality of life
scores as a result of improved musculoskeletal function.
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LONGITUDINAL ASSESSMENT OF PAIN IN PATIENTS WITH KNEE
OSTEOARTHRITIS (OA): USING DATA FROM THE STUDY OF REAL
WORLD THERAPIES (SORT)
F. Rannou y, P.M. Peloso z, S. Rajagopalan x, P. Mavros z, S.V. Everett z,
N. Arden k, P. Conaghan{, C.J. Phillips #, R.A. Moore yy,
M. van de Laar zz, S.D. Taylor z. yUniv. of Paris, Paris, France; zMerck
Sharp & Dohme, Inc., Whitehouse Station, NJ, USA; xMedData Analytics,
Inc., East Brunswick, NJ, USA; kUniv. of Southampton, Southampton,
United Kingdom; {Univ. of Leeds, Leeds, United Kingdom; # Swansea
Univ., Swansea, United Kingdom; yyOxford Univ., Oxford, United
Kingdom; zzUniv. of Twente, Enschede, Netherlands
Pain is a key concern for patients suffering with osteoarthritis (OA) and
is one of the most common reasons for seeking care from a general
practitioner. In this analysis, inadequate pain relief (IPR) was deﬁned as
a score of >4 on the Brief Pain Inventory (BPI) average pain question.
Characterizing the variability of knee OA pain is critical in providing
clinical insight and initiating effective treatment plans.
Purpose: The objective was to examine variability of average pain
scores, pain severity and WOMAC pain subscale scores over 12 months
in knee OA patients who reported IPR at baseline as compared to those
who reported non-IPR using data from SORT
Methods: OA knee patients > 50 years who required medicinal thera-
pies were recruited from physicians’ practices at 53 centres in 6 Euro-
pean countries. Pain was assessed by the (BPI) using average pain score
and pain severity and the WOMAC Pain subscale. Descriptive statistics
were used to describe and contrast IPR and non-IPR cohorts over 12
months.
Results: A total of 1284 patients were enrolled with 1187 eligible for
evaluation and 53.8% met the deﬁnition of IPR at baseline. Fluctuations
in average pain score, pain severity, and WOMAC pain were minimal.
When contrasting IPR vs. non-IPR cohorts, the magnitude of the vari-
ability was similar overtime based on group level standard deviations.
Additionally, statistically signiﬁcant differences between the cohorts
remained regardless of the pain measures (p < 0.0001).
Conclusions: Patients with IPR appear to have stable disease and
remain in IPR over time. Pain levels were relatively stable in this pop-
ulation suggesting the importance of initially treating OA pain with
alternative therapies to avoid IPR.398
SERVICE PROVISION FOR PATIENTS WITH CHRONIC PAIN AFTER
KNEE REPLACEMENT: AN EVALUATION OF CURRENT PRACTICE IN
HIGH VOLUME ORTHOPAEDIC CENTRES
V. Wylde, F. MacKichan, S. Dixon, R. Gooberman-Hill. Univ. of Bristol,
Bristol, United Kingdom
Background: Total knee replacement is one of the most commonly
performed elective surgical procedures. The operation is usually con-
ducted to relieve pain and improve function, but recent studies indicate
that up to 20% of patients experience chronic post-surgical pain (CPSP)
after total knee replacement; this equates to around 16,000 new cases
of CPSP in the UK each year. The wider literature on chronic pain indi-
cates that people with chronic pain encounter patchy service provision.
People with CPSP after knee replacement have already undergone
major surgery for pain, and follow-up after surgery may have a role in
care and pain management. However, we do not know what services
are on offer to this group, nor whether there is consistency in service
provision including identiﬁcation of need and any associated referral
processes. We therefore conducted a survey to scope current UK service
provision for patients with CPSP after total knee replacement.
Methods: This ongoing project is funded through a National Institute
for Health Research (NIHR) Programme Development Grant on the
treatment and management of chronic pain after total knee replace-
ment (the STAR programme). The project was conducted as a service
evaluation of services at high volume NHS orthopaedic centres across
the UK. The 23 NHS orthopaedic centres that conduct 500 or more
primary total knee replacements per year were identiﬁed from the
National Joint Registry. Contact was made with a key health pro-
fessional at each centre who was familiar with the processes of post-
operative assessment and follow-up. A structured telephone interview
was conducted to obtain information about usual patient pathways at
the different centres. Questions focused on identiﬁcation, triage,
treatment, management, and referral of patients with CPSP after total
knee replacement. Information was recorded on a standardised pro-
forma and entered into an Access database. Information was then col-
lated and summarised in Excel.
Results: The survey has been completed by 14/23 NHS orthopaedic
centres. Data collection is ongoing, with completion by February 2014.
All centres routinely follow-up patients at 6 weeks after total knee
replacement, although the provision and timing of subsequent
appointments vary. The majority of centres do not have a speciﬁc time
point at which patients are diagnosed with CPSP; in those that do, time
points range from 4.5–18 months post-operative. When assessing pain
levels, most centres use patient narrative, and there is some use of a
standardised tool, most frequently a visual analogue scale. Four centres
reported using a standardised protocol for assessment of patients with
CPSP, and two centres reported use of a standardised protocol for
management and treatment. Treatment and management options
offered to patients vary between and within centres, and include fur-
ther orthopaedic interventions, referral to pain management services,
analgesia review, and referral for physiotherapy.
Conclusion: This survey of current service provision for patients with
CPSP after total knee replacement identiﬁed national variation in the
identiﬁcation, assessment and management of these patients. Although
some centres have developed a care pathway for patients with CPSP, the
majority of centres lack standardised protocols to guide care provision.
This highlights the potential to develop and evaluate standardised
referral pathways and integrated service provision for patients with
CPSP after total knee replacement.
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KNEE ARTHRITIS: A CONFIRMED BURDEN
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Purpose: Arthritis is a joint disease characterised by progressive deg-
radation of the cartilage. Arthritis can cause suffering in an acute
manner called “inﬂammatory ﬂare-up”, or in a more chronic manner
leading to sometimes severe disability, which affects the everyday life of
patients. Among the different locations of arthritis, arthritis of the knee
